Strs Ohio Has $392,000 Stock Position in Option Care Health, Inc. $OPCH

Strs Ohio trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH) by 74.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,300 shares of the company’s stock after selling 35,900 shares during the quarter. Strs Ohio’s holdings in Option Care Health were worth $392,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of OPCH. Royal Bank of Canada lifted its stake in shares of Option Care Health by 20.7% in the first quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after buying an additional 39,661 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Option Care Health by 162.6% in the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after buying an additional 25,777 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of Option Care Health in the first quarter worth $208,000. Invesco Ltd. lifted its stake in shares of Option Care Health by 2.7% in the second quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after buying an additional 7,678 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Option Care Health by 528.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after buying an additional 1,183 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on OPCH shares. Truist Financial set a $30.00 price objective on shares of Option Care Health in a research note on Friday, May 1st. Jefferies Financial Group restated a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a research note on Tuesday, January 13th. Citizens Jmp restated a “market outperform” rating and issued a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a research note on Wednesday. Finally, JPMorgan Chase & Co. cut their target price on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $31.25.

Option Care Health Price Performance

NASDAQ:OPCH opened at $20.51 on Monday. The stock has a market cap of $3.22 billion, a P/E ratio of 15.90, a PEG ratio of 1.14 and a beta of 0.68. Option Care Health, Inc. has a one year low of $18.01 and a one year high of $36.80. The company has a fifty day moving average price of $28.29 and a 200 day moving average price of $30.61. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts anticipate that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

More Option Care Health News

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Director Timothy P. Sullivan bought 24,154 shares for about $500,000, boosting his ownership by 49%, which investors may view as a confidence signal from management. Sullivan SEC Filing
• Positive Sentiment: Analyst sentiment remains constructive overall, with the consensus still at “Moderate Buy,” and Morgan Stanley reaffirmed an “Overweight” rating. Analyst Recommendation
• Neutral Sentiment: The company is drawing attention ahead of its appearance at the Bank of America Health Care Conference, which could provide more color on execution and guidance. Conference Notice
• Negative Sentiment: Multiple law firms launched securities-fraud investigations and shareholder-loss alerts after Option Care Health’s weaker-than-expected Q1 results and reduced outlook, adding legal and reputational overhang. Holzer Alert
• Negative Sentiment: Q1 earnings were mixed: EPS beat estimates, but revenue missed and management lowered full-year revenue guidance, fueling concerns about slowing growth and future execution. Earnings and Guidance

Insider Activity at Option Care Health

In related news, CEO John Charles Rademacher bought 12,500 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the acquisition, the director directly owned 450,000 shares in the company, valued at approximately $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 73,264 shares of company stock worth $1,548,316 in the last ninety days. 1.70% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.